EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,359,000 | +4.3% | 72,136 | -4.9% | 0.02% | -53.5% |
| Q3 2020 | $3,222,000 | +33.5% | 75,836 | +50.8% | 0.04% | +126.3% |
| Q2 2020 | $2,413,000 | -99.9% | 50,296 | -2.3% | 0.02% | -17.4% |
| Q1 2020 | $2,369,000,000 | -30.8% | 51,496 | -9.6% | 0.02% | 0.0% |
| Q4 2019 | $3,424,000,000 | +102661.1% | 56,996 | -3.2% | 0.02% | 0.0% |
| Q3 2019 | $3,332,000 | +0.8% | 58,896 | -0.8% | 0.02% | 0.0% |
| Q2 2019 | $3,307,000 | +22.4% | 59,396 | +11.0% | 0.02% | +21.1% |
| Q1 2019 | $2,701,000 | +26.0% | 53,496 | +0.6% | 0.02% | +5.6% |
| Q4 2018 | $2,143,000 | -27.3% | 53,196 | +25.2% | 0.02% | -14.3% |
| Q3 2018 | $2,946,000 | – | 42,496 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |